Compare BBUC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBUC | RGEN |
|---|---|---|
| Founded | 2022 | 1981 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 6.6B |
| IPO Year | 2015 | 1995 |
| Metric | BBUC | RGEN |
|---|---|---|
| Price | $31.46 | $130.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 12 |
| Target Price | $41.00 | ★ $167.67 |
| AVG Volume (30 Days) | 339.8K | ★ 1.1M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.75% | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | ★ $141,236,000.00 |
| Revenue This Year | N/A | $14.30 |
| Revenue Next Year | N/A | $14.52 |
| P/E Ratio | ★ N/A | $879.73 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $28.29 | $100.99 |
| 52 Week High | $38.25 | $175.77 |
| Indicator | BBUC | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 50.51 | 41.49 |
| Support Level | $29.29 | $127.63 |
| Resistance Level | $31.92 | $131.53 |
| Average True Range (ATR) | 1.03 | 6.21 |
| MACD | 0.15 | -2.20 |
| Stochastic Oscillator | 79.90 | 11.05 |
Brookfield Business Corp is the operator of vital industrial and business services operations. The company focuses on acquiring market businesses for value, execute its operational improvement plans to increase cash flows and recycle capital to compound long-term growth. Geographically, it derives maximum revenue from the United States, and the rest from Europe, Brazil, Australia, Canada, and others. It operates in four segments within particular sectors namely: business services, infrastructure services, industrials, and corporate. The company derives maximum revenue from Industrials segment engaged in energy storage operations, engineered components manufacturing operations, water and wastewater operations, electric heat tracing systems manufacturer, and other industrials operations.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.